These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11145667)

  • 1. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice.
    Judkowski V; Pinilla C; Schroder K; Tucker L; Sarvetnick N; Wilson DB
    J Immunol; 2001 Jan; 166(2):908-17. PubMed ID: 11145667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
    You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
    J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells.
    Kim SK; Tarbell KV; Sanna M; Vadeboncoeur M; Warganich T; Lee M; Davis M; McDevitt HO
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14204-9. PubMed ID: 15381770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide of glutamic acid decarboxylase 65 can recruit and expand a diabetogenic T cell clone, BDC2.5, in the pancreas.
    Dai YD; Jensen KP; Lehuen A; Masteller EL; Bluestone JA; Wilson DB; Sercarz EE
    J Immunol; 2005 Sep; 175(6):3621-7. PubMed ID: 16148106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
    Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
    J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.
    Quinn A; McInerney MF; Sercarz EE
    J Immunol; 2001 Aug; 167(3):1748-57. PubMed ID: 11466400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
    Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
    J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
    Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
    J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
    Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
    J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells.
    Judkowski VA; Allicotti GM; Sarvetnick N; Pinilla C
    Diabetes; 2004 Sep; 53(9):2301-9. PubMed ID: 15331539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
    Boyton RJ; Lohmann T; Londei M; Kalbacher H; Halder T; Frater AJ; Douek DC; Leslie DG; Flavell RA; Altmann DM
    Int Immunol; 1998 Dec; 10(12):1765-76. PubMed ID: 9885897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.
    Nikoopour E; Sandrock C; Huszarik K; Krougly O; Lee-Chan E; Masteller EL; Bluestone JA; Singh B
    J Immunol; 2011 Apr; 186(7):3831-5. PubMed ID: 21357258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
    Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
    Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice.
    You S; Chen C; Lee WH; Brusko T; Atkinson M; Liu CP
    J Immunol; 2004 Dec; 173(11):6777-85. PubMed ID: 15557171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo.
    Wilson SS; White TC; DeLuca D
    J Immunol; 2001 Jul; 167(1):569-77. PubMed ID: 11418696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
    Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T
    Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
    Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
    J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder.
    Stratmann T; Apostolopoulos V; Mallet-Designe V; Corper AL; Scott CA; Wilson IA; Kang AS; Teyton L
    J Immunol; 2000 Sep; 165(6):3214-25. PubMed ID: 10975837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.